Thrombophilia screening

Revision as of 21:30, 25 June 2016 by Asiri Saumya Ediriwickrema (talk | contribs) (wrote section)
Jump to navigation Jump to search

Thrombophilia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thrombophilia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Thrombophilia screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Thrombophilia screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thrombophilia screening

CDC on Thrombophilia screening

Thrombophilia screening in the news

Blogs on Thrombophilia screening

Directions to Hospitals Treating Thrombophilia

Risk calculators and risk factors for Thrombophilia screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Asiri Ediriwickrema, M.D., M.H.S. [2]

Overview

Screening

  • The American Society of Hematology recommends against thrombophilia screening in adult patients with venous thrombosis in the setting of major transient risk factors[1].
    • Major transient risk factors including: surgery, trauma, or prolonged immobility.
    • However, patients who have significant risk factors including a positive family history or concurrent treatment with hormonal therapies should seek expert consultation.
  • Thrombophilia screening can be expensive, and are often performed at inappropriate times.
  • Refer to thrombophilia laboratory findings for more information on specific screening tests.

References

  1. Hicks LK, Bering H, Carson KR, Kleinerman J, Kukreti V, Ma A; et al. (2013). "The ASH Choosing Wisely®campaign: five hematologic tests and treatments to question". Hematology Am Soc Hematol Educ Program. 2013: 9–14. doi:10.1182/asheducation-2013.1.9. PMID 24319155.

Template:WH Template:WS